Da miyagun ƙwayoyi "Avastin" a ophthalmology: reviews, umarnin don yin amfani da abun da ke ciki

A magani, akwai lokuta a lokacin da kayan aikin raya domin lura da wasu cututtuka, nuna sakamako mai kyau a lura da sauransu. Wannan na faruwa a sakamakon yawa gwaje-gwajen kafin miyagun ƙwayoyi kai mabukaci. Wannan ya faru tare da miyagun ƙwayoyi ci gaba domin lura da ciwon daji marurai, suna "Avastin". A ophthalmology da kuma sake dubawa na magani da ya tilasta wa zaton, ga abin da manufa da kuma da abin da cuta shi ne mafi alhẽri a yi amfani da miyagun ƙwayoyi.

"Avastin"

Asarar wahayi - daya daga cikin bakin ciki na mutum tsufa da tauraron dan adam. Har kwanan nan, mafi yawan matakai a cikin ido ya quite wuya don sarrafa, amma a 'yan shekarun nan a ophthalmology yi binciken cewa sun yarda su hana ci gaban hatsari cututtuka a makanta.

A saboda wannan dalili, daban-daban kungiyoyin na kwayoyi suna amfani da, misali, amfani da babban rabo mai girma domin lura da ciwon daji wakili "Avastin" a ophthalmology. Reviews marasa lafiya tabbatar da cewa da miyagun ƙwayoyi yana da wani babban mataki na yadda ya dace. Amma domin mu fahimci yadda shi ne tasiri, shi wajibi ne a yi la'akari da tsarin ba da ido ailments.

sunadaran da cuta ci gaba

Asarar hangen nesa shi ne saboda mahaukaci yaduwa na jini capillaries. Kunno kai sabon tasoshin girma ta cikin membrane, karya da tsarin da ido. Haka kuma, yawan jini triggers m hemorrhage, wanda za a iya ji ta mutumin da shafi ingancin hangen nesa. Broken capillaries scars, da kuma babban adadin connective nama na akan tantanin ido karya kan aiwatar da ciyar da ido.

Wannan batu za a iya daukan masomin na gani hanawa. Mahimmanci, wannan wahayi, a cikin ci gaban somatic Pathology ba kaucewa rasa, kamar yadda da na gefe yawanci kiyaye su. Duk da haka, da ingancin rayuwa da rage-rage muhimmanci.

Duk da cewa hoton da cutar dubi musamman depressing, tare da dace ganewar asali na Pathology za a iya tsaya a kiyaye wahayin. A saboda wannan dalili, da kuma amfani da miyagun ƙwayoyi "Avastin" a ophthalmology. Reviews da marasa lafiya da likitoci ya tabbatar da m statistics.

Ta yaya miyagun ƙwayoyi

"Avastin" shi ne wani anticancer wakili, shi da ake amfani a Oncology shekaru da yawa da kuma nuna kyakkyawan sakamako. Yadda yake aiki - a kan aiwatar da tarewa nama growths, mahaukaci cell division. Saboda haka, halting ci gaban da sabon jini, shi da gusar da Sanadin cutar da kanta.

Na dogon lokaci akwai shakku ga ko zai iya samar da ake so warkewa sakamako Cancer miyagun ƙwayoyi "Avastin" a ophthalmology. Reviews na masana kimiyya da kuma likitoci sun ce da kwayoyin nauyi na aiki sashi ne da muni: shi ne wajen sau uku da taro na kwayoyin wasu kwayoyi da wannan sakamako. Saboda haka, a ka'idar, da miyagun ƙwayoyi iya ba shawo kan retinal membrane Layer, ya kuma inganta samar da warkewa effects.

Amma bisa ga bincike, "Avastin" daidai ratsa cikin duk yadudduka na akan tantanin ido, rage kudi na yaduwa daga jini capillaries. Tare dace ganewar asali da kuma lura za a iya qaddamar zuwa cikakken adana hangen nesa.

illa

Idan muka yi la'akari da miyagun ƙwayoyi "Avastin", umarnin don amfani, reviews da analogues tare da mai shiryar da yin amfani da magana na musamman game da ciki liyafar, wanda yakan auku a lura da ciwon daji. Saboda haka, gefen sakamakon da miyagun ƙwayoyi ne kamar haka:

• ciki na jini.
• hauhawar jini.
• magudi a cikin narkewa kamar fili.
• proteinuria.
• dermatitis.
• neuropathy.
• asthenia.

Jerin illa lokacin amfani da miyagun ƙwayoyi a lokacin jiyya ne sosai m, kamar yadda a lokacin da yin amfani da wani magani domin lura da ciwon daji.

Aikace-aikace a ophthalmology

Amma a cikin wannan harka da miyagun ƙwayoyi ba a gudanar intravenously, kuma kai tsaye zuwa cikin da vitreous. Kuma abu na biyu, da sashi ne muhimmanci daban-daban daga abin da aka yi amfani da Oncology. Alal misali, allura intravenously game da 500 MG na da miyagun ƙwayoyi, yayin da ido - kawai 1.25 MG.

Duk da haka, a gefe daya sakamako na karbar "Avastin" wanzu: zub da jini a shafin na allura, kona abin mamaki da kuma concomitant tearing. Babu tsanani m bayyanar cututtuka da aka gano ko dai a gudanar da bincike, ko a yi.

dosing

1.25 MG sashi ne gudanar a cikin vitreous jiki da zarar wata daya, ko uku, ko hudu sau. Za ka iya sa'an nan tantance muhimmancin miyagun ƙwayoyi far "Avastin" a ophthalmology. Reviews da marasa lafiya nuna cewa nan da nan bayan wata hanya na kyautata a gani acuity lura a 4 na 10 batutuwa. A 6 daga 10 mutane magani kaiwa zuwa karfafawa daga view, cewa shi ne, don rage kudi na ci gaban da yaduwa na capillary scarring.

A sakamakon haka ne cewa akan tantanin ido zama sirara, cewa shi ne, qara ta permeability da kuma ikon da ido nama. Yawanci, da haƙuri ji kyautata a gani acuity bayan na farko da allura da kuma m injections kawai karfafa sakamako. Sau nawa ka bukatar maimaita allura, dangane da ilimin halittàr jiki da mutum. Bisa kididdigar da, na gaba shakka daga injections da za'ayi a cikin 2-3 watanni.

contraindications

Da miyagun ƙwayoyi ne tsananin ba da shawarar yara, mata masu ciki da masu jego. Har ila yau, babban kula ya kamata a yi amfani da "Avastin" a cikin taron cewa akwai wani abnormality a cikin hanta da kuma kodan, musamman aikin insufficiency na gabobin.

Amma dole ne mu yi la'akari da cewa wadannan contraindications amfani ne kawai a lokacin da gudanar intravenously, da kuma lokacin da bada allura a cikin ido, da suka iya yi ba dacewar. A cikin wani hali, da yanke shawara a kan ganawa da miyagun ƙwayoyi "Avastin" a ophthalmology, reviews na wanda za a iya samu a kowane dace asibitin, likita ya yi.

Duk da haka, ya kamata a tuna da cewa gargajiya da yin amfani da miyagun ƙwayoyi, da likitoci karfi rika kare kansu domin kauce wa maras so ciki. Amfani da miyagun ƙwayoyi a matsayin magani ga idanu, ma, ya kamata la'akari da wannan bayani, shiga a cikin tsarin iyali.

analogs

A duniya a hanya don ajiye view amfani da na dogon lokaci, amma wannan manufa amfani da wasu kwayoyi kamar Macugen da Lucentis. Amma a 'yan shekarun nan, an fi kuma mafi nazarin cewa ce cewa "Avastin" ne sosai tasiri a ophthalmology. Amma dai babu wani bayani game da dogon lokacin da sakamakon yin amfani da miyagun ƙwayoyi domin lura da ido, shi zai zama a hukumance da wani magani domin lura da ciwon daji siffofin maruran.

Don kwanan wata, a cikin Saka-sanarwa ba ce wani abu game da magani daga ido. Saboda haka, kawai tushen bayani a kan yin amfani da "Avastin" miyagun ƙwayoyi a ophthalmology - reviews. Price da miyagun ƙwayoyi ne quite m, sa shi mafi araha idan aka kwatanta da takwarorina.

Kalmar "analog" kullum tana nufin wani magani da cewa yana da irin wannan tsarin, wannan aiki sashi. A cikin Rasha pharmaceutical kasuwar da kwayoyi akwai, wanda za a iya ƙaddara ta hanyar kwatanta abun da ke ciki, bayan ya yi karatu da takardun, wanda sun hada da a haɗe zuwa da miyagun ƙwayoyi "Avastin" umurci manual. Analogues, da farashin jeri daga araha ga quite tsada, da irin wannan jerin alamomi. Amma wannan inji na mataki ne saboda wasu aka gyara.

Wadannan kwayoyi, wanda za a iya samu a wani ɗakin shan magani, sun hada da:

• "Arzerra."
• "Atsellbiya".
• "Vectibix".
• "Herceptin lyophilisate".
• "Herceptin".
• "Campath".
• "MabThera".
• "Pereta."
• "Removab."
• "Rituximab".
• "Erbitux".

The inganci na aikace-aikace

Official magani a yau ba ya bayar da shawarar yin amfani da "Avastin" a ophthalmology. Reviews da marasa lafiya da yawa da kyau, amma akwai nauyi mataki na hadarin, wanda bukatar sani.

Akwai rikitarwa hade da miyagun ƙwayoyi "Avastin": Umarni don amfani a ophthalmology (wakilan kimiyya sake dubawa da sauran kafofin kazalika) ba da damar yin amfani da kudi a cikin jiyya na ido. A manufacturer da miyagun ƙwayoyi a hukumance ya furta cewa ba ainihin kuma wani Generic version na miyagun ƙwayoyi "Bevacizumab", samar a Rasha kamata ba a yi amfani a ophthalmology. Tabbacin wannan bayani za a iya samu a shafin Roszdravnadzor.

Amma a kan wasu albarkatu, kamar shafukan sadaukar da ophthalmology, sau da yawa za ka iya samun bayani a kan yadda da miyagun ƙwayoyi ne sosai tasiri a cikin cututtuka na ido. Wannan shi ne saboda gaskiyar cewa kimiyya da bincike a kan yin amfani da wannan magani da aka gudanar da za'ayi a yanzu, da nuna sakamako mai kyau. Duk da haka, kafin dacewa bayanai ne cikakken aminci da miyagun ƙwayoyi a kan bango na high dace, da umarnin za a tabbatar da ba za a kunshe a cikin sashe "Alamu for Amfani".

amfani lokuta

A wannan batun, "Avastin" da aka yi amfani da kawai a lokuta da gaggawa, idan madadin shi ne cikakken asarar hangen nesa. A gwajinsa, daya daga cikin kananan dakunan shan magani Rasha gano cewa allura "Avastin" bai kai ga tsanani sakamakon, ba su gani sosai, kuma bai kai ga makanta. Amma kokawar majinyata na tearing da kuma kona a idanu.

Saboda haka, "Avastin" - tasiri sosai miyagun ƙwayoyi domin lura da ciwon daji siffofin maruran. Yi cewa ya zama kai "Avastin" a ophthalmology, ratings marasa lafiya yana yawanci gaskiya ma. Amma lokacin da zabi bukatar koma ga yin amfani da kawai wadanda da kwayoyi da aka musamman tsara don warware wata matsala musamman, musamman a cikin Pharmaceutical kayayyakin kasuwar riga akwai musamman kayan aikin da za su iya rage ci gaban m retinopathy da kuma rigar nau'i na AMD.

Saboda haka, "Avastin" za a iya amfani da kawai a cikin matsanancin karkashin kusa likita dubawa.